Literature DB >> 18590341

Medications for premature neonates: healthcare considerations.

Hervé Walti.   

Abstract

Mesh：

Substances：

Year:  2008        PMID： 18590341     DOI： 10.2165/00148581-200810040-00001

Source DB:  PubMed          Journal:  Paediatr Drugs        ISSN： 1174-5878            Impact factor:   3.022


× No keyword cloud information.
  16 in total

1.  Use of antimicrobial agents in United States neonatal and pediatric intensive care patients.

Authors:  Lisa A Grohskopf; W Charles Huskins; Ronda L Sinkowitz-Cochran; Gail L Levine; Donald A Goldmann; William R Jarvis
Journal:  Pediatr Infect Dis J       Date:  2005-09       Impact factor: 2.129

2.  EU offers incentives to firms to produce medicines for children.

Authors:  Rory Watson
Journal:  BMJ       Date:  2006-06-10

3.  Are rare diseases still orphans or happily adopted? The challenges of developing and using orphan medicinal products.

Authors:  James W Dear; Pajaree Lilitkarntakul; David J Webb
Journal:  Br J Clin Pharmacol       Date:  2006-09       Impact factor: 4.335

4.  Unlicensed and off-label drug use in an Australian neonatal intensive care unit.

Authors:  Colm P F O'Donnell; Robyn J Stone; Colin J Morley
Journal:  Pediatrics       Date:  2002-11       Impact factor: 7.124

Review 5.  Cardiovascular support in preterm infants.

Authors:  Jacquelyn R Evans; Billie Lou Short; Krisa Van Meurs; Hari Cheryl Sachs
Journal:  Clin Ther       Date:  2006-09       Impact factor: 3.393

Review 6.  Criteria supporting the study of drugs in the newborn.

Authors:  Robert M Ward; William E Benitz; Daniel K Benjamin; Lillian Blackmon; George P Giacoia; Mark Hudak; Tamar Lasky; William Rodriguez; Arzu Selen
Journal:  Clin Ther       Date:  2006-09       Impact factor: 3.393

7.  The newborn drug development initiative.

Authors:  George P Giacoia; Debra L Birenbaum; Hari Cheryl Sachs; Donald R Mattison
Journal:  Pediatrics       Date:  2006-03       Impact factor: 7.124

8.  A prospective study of adverse drug reactions in hospitalized children.

Authors:  I Martínez-Mir; M García-López; V Palop; J M Ferrer; E Rubio; F J Morales-Olivas
Journal:  Br J Clin Pharmacol       Date:  1999-06       Impact factor: 4.335

9.  Caffeine therapy for apnea of prematurity.

Authors:  Barbara Schmidt; Robin S Roberts; Peter Davis; Lex W Doyle; Keith J Barrington; Arne Ohlsson; Alfonso Solimano; Win Tin
Journal:  N Engl J Med       Date:  2006-05-18       Impact factor: 91.245

10.  The impact of unlicensed and off-label drug use on adverse drug reactions in paediatric patients.

Authors:  Antje Neubert; Harald Dormann; Jutta Weiss; Tobias Egger; Manfred Criegee-Rieck; Wolfgang Rascher; Kay Brune; Burkhard Hinz
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.